[1] Nagamine A, Takenaka M, Aomori T, et al.Effect of genetic poly- morphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus[J]. Am J Health Syst Pharm, 2012, 69(23): 2072-2078. [2] Inflammatorry Bowel Disease Group, Chinese Society of Gastroente- rology, Chinese Medical Association. Chinese consensus on diagnosis and treatment of inflammatory bowel disease(Beijing, 2018)[J]. Chinese Journal of Practical Internal Medicine(中国实用内科杂志), 2018, 38(9): 796-813. [3] Feuerstein JD, Nguyen GC, Kupfer SS, et al.American gastro- enterological association institute guideline on therapeutic drug monitoring in inflammatory bowel disease[J]. Gastroenterology, 2017, 3(153): 827-834. [4] Rashidi MR, Beedham C, Smith JS, et al.In Vitro Study of 6- mercaptopurine Oxidation Catalysed by Aldehyde Oxidase and Xanthine Oxidase[J]. Drug Metab Pharmacokinet, 2007, 22(4): 299-306. [5] Yamamoto T, Moriwaki Y, Takahashi S, et al.Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type[J]. Metab Clin Exp, 2003, 52(11): 1501-1504. [6] Smith MA, Marinaki AM, Arenas M, et al.Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease[J]. Aliment Pharmacol Ther, 2009, 30(4): 375-384. [7] Kurzawski M, Dziewanowski K, Safranow K, et al.Polymorphism of gene involved in purine metabolism (XHD, AOX1, MOCOS) in kidney transplant recipients receiving azathioprine[J]. Ther Drug Monit, 2012, 34(3): 266-274. [8] Dervieux T, Boulieu R.Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC[J]. Clin Chem, 1998, 44(3): 551-555. [9] Zhou L, Zhong DF, Chen XY.Research advances in non-P450- mediated drug oxidative metabolism[J]. Acta Pharmaceutica Sinica(药学学报), 2017, 52(1): 8-18. [10] Diao XX, Chen XY.The role of aldehyde oxidase in drug meta- bolism[J]. Journal of Baoji University of Arts and Sciences(宝鸡文理学院学报), 2014, 34(2): 26-38. [11] Stiburkova B, Pavelcova K, Petru L, et al.Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type )[J]. Toxicol Appl Pharmacol, 2018, 15(353): 102-108. [12] Lamb CA, Kennedy NA, Raine T, et al.British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults[J]. Gut, 2019, 68(suppl 3): s1-s106. [13] Gordon C, Amissah-arthur MB, Gayed M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults[J]. Rheumatology (Oxford), 2018, 57(1): e1-e45. [14] Zhang YT, Fan Y, Zhao N, et al.Azathioprine associated pancyto- penia in a patient without TPMT gene mutation[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2011, 8(10): 634-636. [15] Fei X, Shu Q, Zhu H, et al.NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients[J]. Front Pharmacol, 2018,9: 460-467. [16] Pang XY, Liu XY.A case of severe myelosuppression induced by azathio- prine[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(1): 59-60. [17] Kim SY, Shin JH, Park JS, et al.NUDT15 p.R139C variant is common and strongly associated with azathioprine-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases[J]. J Neurol Sci, 2017, 378(4): 64-68. [18] Kakuta Y, Naito T, Onodera M, et al.NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD[J]. Pharmacogenomics J, 2016, 16(3): 280-285. |